ArticleCells2022

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of

Shuangshuang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.